EirGenix, Inc.
Albert Chung-Huan Lin is a Business Development Director at EirGenix. Inc. Albert Chung-Huan has extensive experience in the pharmaceutical and biotech industry, specializing in biologics, biosimilar, and ADC CDMO and co-development. Albert has held various managerial positions in companies such as ScinoPharm Taiwan, TWI Pharmaceuticals Inc, Synthetic Genomics, and Panlabs Biologics & CDIB Bioscience Venture Management. Albert Chung-Huan holds degrees in Agricultural Chemistry, Biochemistry, and an MBA in Finance & Entrepreneurship. Albert is known for their strategic planning, market analysis, and successful deal-making skills.
This person is not in any offices
EirGenix, Inc.
2 followers
EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing